University of Utah
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Utah sits in the top decile of US sponsors by registered trial count (#40 of 15,742 sponsors by registered trial count).
University of Utah: 818 sponsored US clinical trials, 138 recruiting.
University of Utah sponsors 818 registered US clinical trials on ClinicalTrials.gov, 138 of them currently recruiting, and 492 completed. 45 of these trials are in Phase 3-4 (later-stage) and 268 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Low Back Pain, with 8 trials.
Top-decile sponsor footprint
University of Utah ranks in the top decile of sponsors by registered trial count (#40 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
492 of 611 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
818 total, page 1 of 17
Microvideos for Improving HPV Vaccination Among Childhood Cancer Survivors
NCT07648953
Lesion-tailored, Fundus-controlled Perimetry in Geographic Atrophy (GA).
NCT07582042
External Beam Radiotherapy Followed by Bispecific Antibody Therapy for Relapsed/Refractory DLBCL
NCT07528352
Culturally Engaged REcovery: MOms Connected Through Native communitY
NCT06747442
Financial Counseling for Dementia Family Caregivers in Early and Middle Adulthood
NCT07681401
Multimodal Telerehabilitation of Rural Patients With Advanced Prostate Cancer
NCT07093177
Personalizing Financial Incentives
NCT07225426
Confirming the Effects of Acupuncture Treatments to Relieve Symptoms of Gulf War Illness
NCT06716411
Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma
NCT06365619
Aim 3: Pilot Study of a Serious Game to Promote Transition Readiness Skills
NCT07042334
Testing a Tailored Approach to Long-Term Weight Loss Success
NCT07577765
A Novel mHealth Intervention to Improve Outcomes of Children With Medical Complexity
NCT06883045
Personalized Ultrasonic Brain Stimulation for Fibromyalgia
NCT07361328
Platelet Rich Plasma for Musculoskeletal Conditions
NCT07231471
Nighttime Synchrony of Your Nutrition and Circadian Health
NCT07329283
Helping Lupus Patients Manage Fibromyalgia Symptoms Through Emotional Awareness and Expression Therapy (EAET)
NCT07282392
PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study
NCT06945484
Enhancing Mammography Programs for Outreach, Wellness, Education, and Resources (EMPOWER) in Underserved Populations Study
NCT07029490
Nurturing Exercise Routine for Greater Improvement in Zest and Energy on Enhertu
NCT07203378
Simulation-Free, Single-Fraction Palliative Radiation Therapy for Treatment of Bone Metastases
NCT07202273
Optimal PSA Triggered Individual Management of Androgen Sensitive Prostate Cancer
NCT07216248
SAVE Trial: SAfe Opioid Use Video Education
NCT07044583
Developing an Innovative Decision Support Tool for Pediatric Neuromuscular Scoliosis
NCT07167927
Use of Isatuximab, Dexamethasone and Lenalidomide in a Go-Slow Fashion for Ultra-Frail Patients With Multiple Myeloma
NCT06517017
Clinical Investigation of the Effects of Semiconductor Embedded Therapeutic Garments on Cancer-related Cognitive Impairment in Breast and Gynecological Cancer Patients
NCT07173101
Pemigatinib in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphomas
NCT06300528
Guided Meditation During Radiation Therapy for Breast and Gynecological Malignancies
NCT07166042
Tazemetostat in Combination With Zanubrutinib and Anti-CD20 Monoclonal Antibody in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
NCT06824701
The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue)
NCT07151391
Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy
NCT07390071
Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Survivors
NCT07120100
Loncastuximab Tesirine and Rituximab as Bridging Therapy Before Standard-of-care CAR-T Therapy in Patients With Large B-cell Lymphoma (CORAL)
NCT06788964
Shortened Course of Radiation Therapy After Trans-oral Robotic Surgery in Patients With HPV-Mediated Oropharyngeal Squamous Cell Carcinoma.
NCT07044635
Motorized Prostheses for Lower-limb Amputees
NCT07486063
A Comparison of Renal vs Limb NIRS for Predicting Cardiac Surgery Associated Acute Kidney Injury
NCT06705855
The Beat Pain Better Trial
NCT06932887
Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer
NCT07032584
5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer
NCT06961955
Duloxetine Metabolism and Fibromyalgia
NCT06866444
The SENTRY Study: Testing Whether Changes in Platelet RNA Enhance the Early Diagnosis of Ovarian Cancer
NCT06665945
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples With Implications for Alzheimer's Disease Risk
NCT06649929
Loncastuximab Tesirine and Rituximab Following Stereotactic Radiosurgery in Patients With Central Nervous System Lymphomas (SOLAR)
NCT06607549
Using Nudges to Recruit for Health-Related Research
NCT06857903
PreventT2 Together: Examining the Efficacy of Couple-based Lifestyle Intervention to Prevent Type 2 Diabetes
NCT06690788
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
NCT05826925
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
NCT06387290
Study to Determine How Different Types of Coping Strategies Can Help People Manage Pain and Distress After Surgery
NCT06858202
Pirtobrutinib in Combination With Rituximab in Adults With Untreated Marginal Zone Lymphoma (PIONEER-MZL)
NCT06390956
Topical Tretinoin Prophylaxis for Anti-EGFR Induced Skin Toxicity in Patients With Solid Tumors
NCT06358677
Reach Through Equitable Implementation in Utah
NCT06881069
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 145 |
| Phase 2 | 123 |
| Phase 3 | 18 |
| Phase 4 | 27 |
Therapeutic Areas
What is open in the University of Utah pipeline
138 recruiting of 818 indexed (17% open); 492 completed (60%).
Phase mix: 45 late (III/IV) vs 268 early (I/II) (early-phase heavy).
Top condition: Low Back Pain (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Utah: open-pipeline peers nationwide
Peers matched on 818 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
University of Utah sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 818 trials (± recruiting share)
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
- University of Chicago · 796 trials · 20% recruiting
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- University of California, San Diego · 775 trials · 18% recruiting
Sponsors near 17% open enrollment (± trial volume)
- University of Hawaii · 17% recruiting · 77 trials
- Penn State University · 17% recruiting · 219 trials
- AdventHealth · 17% recruiting · 95 trials
- CSL Behring · 17% recruiting · 71 trials
Related
What to do with this University of Utah page
818 registered trials is a research-attention snapshot, not an endorsement of University of Utah or any single study.
- 138 of University of Utah's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Low Back Pain is the condition University of Utah studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Low Back Pain trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Utah pipeline card: 818 registered trials from official public datasets.Report a data error.